1
|
Kocak P, Oz UC, Bolat ZB, Ozkose UU, Gulyuz S, Tasdelen MA, Yilmaz O, Bozkir A, Sahin F, Telci D. The Utilization of Poly(2-ethyl-2-oxazoline)-b-Poly(ε-caprolactone) Ellipsoidal Particles for Intracellular BIKDDA Delivery to Prostate Cancer. Macromol Biosci 2020; 21:e2000287. [PMID: 33191572 DOI: 10.1002/mabi.202000287] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2020] [Revised: 10/08/2020] [Indexed: 11/10/2022]
Abstract
Prostate cancer is the most common cancer, which is about 15-20% among male cancers worldwide. As most common strategies such as radiotherapy, chemotherapy, or surgery alone can be unsuccessful in the treatment of prostate cancer, this study aims to develop a new approach to deliver newly generated proapoptotic gene, BIKDDA, to androgen independent prostate cancer cells, 22RV1, using new generation nanocarriers called ellipsoids. As far as it is known, this is the first study that assesses the ability of proapoptotic gene BIKDDA to induce apoptosis in prostate cancer cell. BIKDDA encapsulating PEtOx-b-PCL-based ellipsoids are fabricated by solvent-switch method, and their morphology, size, and BIKDDA content are characterized. Gene delivery efficiency of BIKDDA loaded PEtOx-b-PCL ellipsoids is demonstrated by analysis of BIK mRNA expression with real-time PCR. The apoptotic effect of PEtOx-b-PCL ellipsoids loaded with BIKDDA (EPs-BIKDDA) on 22RV1 is shown by Annexin V staining. The obtained results demonstrate that the treatment of 22RV1 cells with EPs-BIKDDA can significantly increase BIK mRNA levels by 4.5-fold leading to cell death. This study not only represents BIKDDA as a potential therapeutic strategy in prostate cancer but also the capacity of ellipsoids as promising in vivo gene delivery vehicles.
Collapse
Affiliation(s)
- Polen Kocak
- Department of Genetics and Bioengineering, Faculty of Engineering and Architecture, Yeditepe University, 26 Agustos Campus, Istanbul, 34755, Turkey
| | - Umut Can Oz
- Department of Pharmaceutical Technology, Faculty of Pharmacy, Ankara University, Yenimahalle, Ankara, 06560, Turkey
| | - Zeynep Busra Bolat
- Department of Genetics and Bioengineering, Faculty of Engineering and Architecture, Yeditepe University, 26 Agustos Campus, Istanbul, 34755, Turkey.,Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Istanbul Sabahattin Zaim University, Kucukcekmece, Istanbul, 34303, Turkey
| | - Umut Ugur Ozkose
- U. U. Ozkose, S. Gulyuz, Dr. O. Yilmaz, Materials Institute, Marmara Research Center, TUBITAK, Gebze, Kocaeli, 41470, Turkey.,Department of Chemistry, Faculty of Science and Letters, Istanbul Technical University, Maslak, Istanbul, 34469, Turkey.,Department of Chemistry, Faculty of Science and Letters, Piri Reis University, Tuzla, Istanbul, 34940, Turkey
| | - Sevgi Gulyuz
- U. U. Ozkose, S. Gulyuz, Dr. O. Yilmaz, Materials Institute, Marmara Research Center, TUBITAK, Gebze, Kocaeli, 41470, Turkey.,Department of Chemistry, Faculty of Science and Letters, Istanbul Technical University, Maslak, Istanbul, 34469, Turkey
| | - Mehmet Atilla Tasdelen
- Department of Polymer Engineering, Faculty of Engineering, Yalova University, Yalova, 77200, Turkey
| | - Ozgur Yilmaz
- U. U. Ozkose, S. Gulyuz, Dr. O. Yilmaz, Materials Institute, Marmara Research Center, TUBITAK, Gebze, Kocaeli, 41470, Turkey
| | - Asuman Bozkir
- Department of Pharmaceutical Technology, Faculty of Pharmacy, Ankara University, Yenimahalle, Ankara, 06560, Turkey
| | - Fikrettin Sahin
- Department of Genetics and Bioengineering, Faculty of Engineering and Architecture, Yeditepe University, 26 Agustos Campus, Istanbul, 34755, Turkey
| | - Dilek Telci
- Department of Genetics and Bioengineering, Faculty of Engineering and Architecture, Yeditepe University, 26 Agustos Campus, Istanbul, 34755, Turkey
| |
Collapse
|